SCHEMBL9986571

SCHEMBL9986571

CNS(=O)(=O)c1ccc(OC2CCC(OC)CC2)c([N+](=O)[O-])c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 1/20 0.51
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
ALDH3A1 P30838 3/20 0.47
ALDH1A1 P00352 5/20 0.46
POLB P06746 1/20 0.44
AGTR1 P30556 1/20 0.43
MEN1 O00255 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA3 P07451 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9980480 0.89 VCAM1 (0.52) VCAM1LMNAMAPTALDH3A1ALDH1A1
SCHEMBL12065809 0.86 VCAM1 (0.47) VCAM1LMNAMAPTALDH3A1ALDH1A1
SCHEMBL12065555 0.81 CA1 (0.48) LMNAMAPTPOLBMEN1KMT2A
SCHEMBL6117960 0.80 ALDH1A1 (0.67) VCAM1LMNAMAPTALDH3A1ALDH1A1
SCHEMBL30871305 0.80 ALDH1A1 (0.67) VCAM1LMNAMAPTALDH3A1ALDH1A1
SCHEMBL12066385 0.79 MAPT (0.72) VCAM1LMNAMAPTALDH3A1ALDH1A1
SCHEMBL9980514 0.74 SMN1; SMN2 (0.54) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL6912644 0.74 VCAM1 (0.58) VCAM1LMNAMAPTALDH3A1ALDH1A1
SCHEMBL1700084 0.73 CA2 (0.49) VCAM1LMNAMAPTALDH1A1POLB
SCHEMBL1700086 0.73 CA2 (0.49) VCAM1LMNAMAPTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011149827-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-12-01 WO disclosed
WO-2011149827-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-12-01 WO disclosed